PortfoliosLab logoPortfoliosLab logo
JNJ vs. KMB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

JNJ vs. KMB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Johnson & Johnson (JNJ) and Kimberly-Clark Corporation (KMB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JNJ achieves a 17.75% return, which is significantly higher than KMB's 8.57% return. Over the past 10 years, JNJ has outperformed KMB with an annualized return of 10.61%, while KMB has yielded a comparatively lower 1.48% annualized return.


JNJ

1D
0.80%
1M
3.43%
YTD
17.75%
6M
17.28%
1Y
62.31%
3Y*
16.71%
5Y*
11.06%
10Y*
10.61%

KMB

1D
2.67%
1M
9.13%
YTD
8.57%
6M
8.36%
1Y
-13.85%
3Y*
-4.19%
5Y*
-0.58%
10Y*
1.48%
*Multi-year figures are annualized to reflect compound growth (CAGR)

JNJ vs. KMB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
JNJ
Johnson & Johnson
17.75%47.48%-4.81%-8.58%5.97%11.44%10.82%16.22%-5.13%24.43%
KMB
Kimberly-Clark Corporation
8.57%-19.86%11.79%-7.08%-1.58%9.66%0.95%24.57%-2.06%9.04%

Correlation

The correlation between JNJ and KMB is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.35

Correlation (3Y)
Calculated over the trailing 3-year period

0.40

Correlation (5Y)
Calculated over the trailing 5-year period

0.43

Correlation (10Y)
Calculated over the trailing 10-year period

0.40

Correlation (All Time)
Calculated using the full available price history since Dec 17, 1984

0.34

Fundamentals

Market Cap

JNJ:

$589.29B

KMB:

$35.56B

EPS

JNJ:

$8.65

KMB:

$5.93

PE Ratio

JNJ:

27.87

KMB:

18.01

PEG Ratio

JNJ:

0.93

KMB:

3.11

PS Ratio

JNJ:

6.08

KMB:

2.15

PB Ratio

JNJ:

7.26

KMB:

19.80

Total Revenue (TTM)

JNJ:

$96.36B

KMB:

$16.54B

Gross Profit (TTM)

JNJ:

$66.60B

KMB:

$5.93B

EBITDA (TTM)

JNJ:

$31.62B

KMB:

$3.07B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JNJ vs. KMB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JNJ
JNJ Risk / Return Rank: 9696
Overall Rank
JNJ Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
JNJ Sortino Ratio Rank: 9898
Sortino Ratio Rank
JNJ Omega Ratio Rank: 9797
Omega Ratio Rank
JNJ Calmar Ratio Rank: 9494
Calmar Ratio Rank
JNJ Martin Ratio Rank: 9595
Martin Ratio Rank

KMB
KMB Risk / Return Rank: 2323
Overall Rank
KMB Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
KMB Sortino Ratio Rank: 2020
Sortino Ratio Rank
KMB Omega Ratio Rank: 1919
Omega Ratio Rank
KMB Calmar Ratio Rank: 2727
Calmar Ratio Rank
KMB Martin Ratio Rank: 3030
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JNJ vs. KMB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Johnson & Johnson (JNJ) and Kimberly-Clark Corporation (KMB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


JNJKMBDifference
Sharpe ratioReturn per unit of total volatility

+4.13

Sortino ratioReturn per unit of downside risk

+5.68

Omega ratioGain probability vs. loss probability

1.65

0.92

+0.73

Calmar ratioReturn relative to maximum drawdown

5.71

-0.47

+6.18

Martin ratioReturn relative to average drawdown

16.62

-0.70

+17.32

JNJ vs. KMB - Sharpe Ratio Comparison

The current JNJ Sharpe Ratio is 3.60, which is higher than the KMB Sharpe Ratio of -0.53. The chart below compares the historical Sharpe Ratios of JNJ and KMB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

JNJ vs. KMB - Drawdown Comparison

The maximum JNJ drawdown since its inception was -50.67%, which is greater than KMB's maximum drawdown of -36.97%. Use the drawdown chart below to compare losses from any high point for JNJ and KMB.


Loading charts...

Drawdown Indicators


JNJKMBDifference

Max Drawdown

Largest peak-to-trough decline

-50.67%

-36.97%

-13.70%

Max Drawdown (1Y)

Largest decline over 1 year

-10.96%

-29.60%

+18.64%

Max Drawdown (3Y)

Largest decline over 3 years

-15.95%

-34.06%

+18.11%

Max Drawdown (5Y)

Largest decline over 5 years

-18.41%

-34.06%

+15.65%

Max Drawdown (10Y)

Largest decline over 10 years

-27.37%

-34.06%

+6.69%

Current Drawdown

Current decline from peak

-2.48%

-23.33%

+20.85%

Average Drawdown

Average peak-to-trough decline

-11.90%

-8.86%

-3.04%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.76%

19.71%

-15.95%

Volatility

JNJ vs. KMB - Volatility Comparison

The current volatility for Johnson & Johnson (JNJ) is 7.01%, while Kimberly-Clark Corporation (KMB) has a volatility of 9.98%. This indicates that JNJ experiences smaller price fluctuations and is considered to be less risky than KMB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JNJKMBDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.01%

9.98%

-2.97%

Volatility (6M)

Calculated over the trailing 6-month period

12.66%

17.53%

-4.87%

Volatility (1Y)

Calculated over the trailing 1-year period

17.39%

26.23%

-8.84%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.99%

20.35%

-3.36%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.54%

21.14%

-2.60%

Dividends

JNJ vs. KMB - Dividend Comparison

JNJ's dividend yield for the trailing twelve months is around 2.17%, less than KMB's 4.76% yield.


PositionTTM20252024202320222021202020192018201720162015
JNJ
Johnson & Johnson
2.17%2.48%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%
KMB
Kimberly-Clark Corporation
4.76%5.00%3.72%3.88%3.42%3.19%3.17%3.00%3.51%3.22%3.22%2.77%

Financials

JNJ vs. KMB - Financials Comparison

This section allows you to compare key financial metrics between Johnson & Johnson and Kimberly-Clark Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00B10.00B15.00B20.00B25.00B20222023202420252026
24.06B
4.16B
(JNJ) Total Revenue
(KMB) Total Revenue
Values in USD except per share items

JNJ vs. KMB - Profitability Comparison

The chart below illustrates the profitability comparison between Johnson & Johnson and Kimberly-Clark Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%20222023202420252026
71.5%
36.9%
Portfolio components
JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.

KMB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kimberly-Clark Corporation reported a gross profit of 1.53B and revenue of 4.16B. Therefore, the gross margin over that period was 36.9%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.

KMB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kimberly-Clark Corporation reported an operating income of 753.00M and revenue of 4.16B, resulting in an operating margin of 18.1%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.

KMB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kimberly-Clark Corporation reported a net income of 521.00M and revenue of 4.16B, resulting in a net margin of 12.5%.


Frequently Asked Questions


JNJ and KMB have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KMB has higher volatility (9.98%) compared to JNJ (7.01%). In terms of maximum drawdown, JNJ dropped -50.67% vs KMB's -36.97%.

JNJ currently has the higher Sharpe Ratio (3.60 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for JNJ and KMB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer